0001225208-21-007707.txt : 20210506
0001225208-21-007707.hdr.sgml : 20210506
20210506211108
ACCESSION NUMBER: 0001225208-21-007707
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210504
FILED AS OF DATE: 20210506
DATE AS OF CHANGE: 20210506
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOBO DONALD E JR
CENTRAL INDEX KEY: 0001196661
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15525
FILM NUMBER: 21899904
MAIL ADDRESS:
STREET 1: C/O EDWARDS LIFESCIENCES
STREET 2: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edwards Lifesciences Corp
CENTRAL INDEX KEY: 0001099800
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 364316614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
BUSINESS PHONE: 9492502500
MAIL ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP.
DATE OF NAME CHANGE: 20090225
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP
DATE OF NAME CHANGE: 20000203
FORMER COMPANY:
FORMER CONFORMED NAME: CVG CONTROLLED INC
DATE OF NAME CHANGE: 19991126
4
1
doc4.xml
X0306
4
2021-05-04
0001099800
Edwards Lifesciences Corp
EW
0001196661
BOBO DONALD E JR
ONE EDWARDS WAY
IRVINE
CA
92614
1
CVP,Strategy/Corp Development
Common Stock
2021-05-04
4
A
0
4000.0000
0.0000
A
52844.8505
D
Common Stock
38158.4268
I
401(k)
Common Stock
123820.0000
I
By Trust
Employee Stock Option (Right to Acquire)
93.3100
2021-05-04
4
A
0
39200.0000
0.0000
A
2022-05-04
2028-05-03
Common Stock
39200.0000
39200.0000
D
Performance Rights
2021-05-04
4
A
0
5000.0000
0.0000
A
2024-05-04
2028-05-03
Common Stock
5000.0000
5000.0000
D
These restricted stock units were granted on May 4, 2021 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator.
These options were granted on May 4, 2021 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments.
Reflects the target number of shares (the Target Award) covered by restricted stock units granted under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program on May 4, 2021 and scheduled to vest on May 4, 2024. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards.
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.
Linda J. Park, Attorney-in-Fact
2021-05-06